Your trusted destination for CME, CPD & Medical Education across the Middle East.
Cincinnati Children’s Hospital
Dr. Anna Peters is a world-renowned pediatric hepatologist, transplant physician, and physician-scientist based at Cincinnati Children's Hospital Medical Center (CCHMC) and the University of Cincinnati College of Medicine. She earned her Doctor of Medicine (MD) alongside a PhD in Molecular and Developmental Biology through a prestigious dual-degree Medical Scientist Training Program (MSTP). She completed her general pediatric residency training followed by advanced subspecialty fellowship training in pediatric gastroenterology, hepatology, and pediatric liver transplantation.
Serving as Medical Director of Pediatric Liver Transplantation at Cincinnati Children's—one of the largest and highest-volume pediatric liver transplant programs in North America—Dr. Peters oversees comprehensive clinical care, organ allocation, and post-transplant survival pathways. Her specialized clinical scope encompasses biliary atresia, Alagille syndrome, progressive familial intrahepatic cholestasis (PFIC), acute pediatric liver failure, metabolic liver disorders (including Wilson disease and alpha-1 antitrypsin deficiency), and pediatric liver transplantation management.
Throughout her tenure at Cincinnati Children's, Dr. Peters has been at the forefront of establishing standardized clinical care pathways for complex hepatobiliary diseases. She collaborates closely with pediatric transplant surgeons,interventional radiologists, pediatric intensivists, and transplant pathologists to optimize perioperative survival, establish steroid-sparing immunosuppression regimens, and minimize graft rejection rates in pediatric organ recipients.
In addition to her clinical and program leadership, Dr. Peters is a dedicated medical mentor and educator at the University of Cincinnati. She actively supervises pediatric gastroenterology and hepatology fellows, transplant scholars, and post-doctoral researchers, directing CME-accredited liver pathology workshops, pediatric transplant masterclasses, and translational laboratory research tracks designed to mentor the next generation of academic pediatric hepatologists.
Dr. Peters leads an active, NIH-funded translational research laboratory investigating the cellular and molecular mechanisms of liver fibrosis, biliary tract development, and liver regeneration. She has authored numerous high-impact peer-reviewed scientific publications in journals such as Hepatology, Gastroenterology, and Journal of Hepatology. Her research portfolio focuses on identifying diagnostic biomarkers for biliary atresia, evaluating novel therapies for cholestatic pruritus, and analyzing long-term outcomes in pediatric liver transplant recipients.
At premier scientific conventions, particularly the 20th SEHA International Pediatric Conference (SIPC 2026) in Abu Dhabi, Dr. Anna Peters serves as a featured international keynote speaker and expert panelist. Translating advanced bench-to-bedside translational hepatology into practical clinical algorithms, she provides pediatricians,gastroenterologists, transplant specialists, and critical care teams across the GCC with actionable strategies to optimize early diagnosis of liver disease, refine post-transplant care, and elevate outcomes for pediatric liver patients worldwide.
